Tata Elxsi and Drager have announced a collaboration to advance critical care innovation in India. As part of this collaboration, Drager is expanding its research and development presence by establishing a new Offshore Development Center (ODC) at Tata Elxsi's facility in Pune. The ODC will focus on developing innovative critical care medical devices for both local and international markets.

This partnership combines Tata Elxsi's design and technology expertise along with Drager's expertise in medical and safety technology. The development center will unite talent from both organizations, dedicated to designing and developing innovative critical care medical devices For deployment in the Operation Theatre (OT) environment worldwide. This central hub will oversee all aspects of critical care product development, from conceptualisation to product design, prototyping, and testing.

The ODC provides a comprehensive critical care equipment testing facility, which is equipped with medical-grade gases, compressors, oxygen cylinders to create test environment, to meet the demanding requirements of the OT setup. Joint commitment towards innovation: This ODC is steadfastly committed to pushing the boundaries of medical innovation. It aims to develop products that adhere to the highest safety and efficacy standards for deployment in critical care settings.

The collaboration between Tata Elxsi and Drager taps into their collective talent to fast-track the development of cost-effective, high-quality medical devices, contributing to a robust healthcare ecosystem that is accessible to everyone. The partnership showcases Indian R&D capabilities on the global stage. This marks Drager's second R&D center in India, showcasing its commitment to Indian innovation and manufacturing capabilities.

Looking ahead, there are plans for expanding the critical care portfolio. By harnessing cutting-edge technologies, the new ODC is set to play a pivotal role in crafting innovative healthcare equipment that addresses the evolving needs of patients and healthcare providers globally.